Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Multiple Sclerosis Centers of Excellence

Menu
Menu
Quick Links
Veterans Crisis Line Badge
My healthevet badge
 

Peginterferon Beta-1a (Plegridy)

Peginterferon beta-1a (Plegridy) is a medication administered by subcutaneous (SC) injection, every two weeks, for the treatment of relapsing forms of MS. Interferon beta-1a pegylanted is theorized to down-regulate proinflammatory cytokines, decrease major histocompatibility antigens, and reduce T-lymphocyte passage across the blood-brain-barrier. Pegylation results in longer effective half-life and, thus, extended dosing intervals. It also reduces formation of neutralizing interferon antibodies (NAbs).

Additional Information


Disclaimer: Links are provided as a convenience and for informational purposes only. They do not constitute an endorsement or an approval by MSCoE of any of the products, services, or opinions of the organization. MSCoE bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.